1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997

2. Elks ML, Sawyer JW, Jr.: Misunderstanding in the classification of diabetes mellitus. What's in a name? West J Med 159:44-49, 1993

3. Rocchini AP: Childhood obesity and a diabetes epidemic. N.Engl.J Med 346:854-855, 2002

4. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, Sherwin RS, Caprio S: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N.Engl.J Med 346:802-810, 2002

5. Herman WH, Fajans SS, Ortiz FJ, Smith MJ, Sturis J, Bell GI, Polonsky KS, Halter JB: Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43:40-46, 1994

6. Bell GI, Xiang KS, Newman MV, Wu SH, Wright LG, Fajans SS, Spielman RS, Cox NJ: Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc.Natl.Acad.Sci.U.S.A 88:1484-1488, 1991

7. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460, 1996

8. Froguel P, Vaxillaire M, Sun F, Velho G, Zouali H, Butel MO, Lesage S, Vionnet N, Clement K, Fougerousse F, .: Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 356:162-164, 1992

9. Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P, .: Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 356:721-722, 1992

10. Chiu KC, Province MA, Permutt MA: Glucokinase gene is genetic marker for NIDDM in American blacks. Diabetes 41:843-849, 1992

11. Kesavan P, Wang L, Davis E, Cuesta A, Sweet I, Niswender K, Magnuson MA, Matschinsky FM: Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2). Biochem.J 322 ( Pt 1):57-63, 1997

12. Velho G, Blanche H, Vaxillaire M, Bellanne-Chantelot C, Pardini VC, Timsit J, Passa P, Deschamps I, Robert JJ, Weber IT, Marotta D, Pilkis SJ, Lipkind GM, Bell GI, Froguel P: Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families. Diabetologia 40:217-224, 1997

13. Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckmann JS, Velho G, Lathrop GM, Froguel P: A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat.Genet. 9:418-423, 1995

14. Hansen T, Eiberg H, Rouard M, Vaxillaire M, Moller AM, Rasmussen SK, Fridberg M, Urhammer SA, Holst JJ, Almind K, Echwald SM, Hansen L, Bell GI, Pedersen O: Novel MODY3 mutations in the hepatocyte nuclear factor-1alpha gene: evidence for a hyperexcitability of pancreatic beta-cells to intravenous secretagogues in a glucose-tolerant carrier of a P447L mutation. Diabetes 46:726-730, 1997

15. Stoffers DA, Ferrer J, Clarke WL, Habener JF: Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat.Genet. 17:138-139, 1997

16. Sovik O, Sagen J, Njolstad PR, Nyland H, Myhr KM: Contributions to the MODY5 phenotype. J Inherit.Metab Dis. 25:597-598, 2002

17. Weng JP, Lehto M, Forsblom C, Huang X, Li H, Groop LC: Hepatocyte nuclear factor-1 beta (MODY5) gene mutations in Scandinavian families with early-onset diabetes or kidney disease or both. Diabetologia 43:131-132, 2000

18. Tager H, Given B, Baldwin D, Mako M, Markese J, Rubenstein A, Olefsky J, Kobayashi M, Kolterman O, Poucher R: A structurally abnormal insulin causing human diabetes. Nature 281:122-125, 1979

19. Reardon W, Ross RJ, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC: Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340:1376-1379, 1992

20. van den Ouweland JM, Lemkes HH, Trembath RC, Ross R, Velho G, Cohen D, Froguel P, Maassen JA: Maternally inherited diabetes and deafness is a distinct subtype of diabetes and associates with a single point mutation in the mitochondrial tRNA(Leu(UUR)) gene. Diabetes 43:746-751, 1994

21. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J: The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N.Engl.J Med 294:739-745, 1976

22. Taylor SI: Lilly Lecture: molecular mechanisms of insulin resistance. Lessons from patients with mutations in the insulin-receptor gene. Diabetes 41:1473-1490, 1992

23. Flier JS: Lilly Lecture: syndromes of insulin resistance. From patient to gene and back again. Diabetes 41:1207-1219, 1992

24. Oral EA: Lipoatrophic diabetes and other related syndromes. Rev.Endocr.Metab Disord. 4:61-77, 2003

25. Berger D, Barroso I, Soos M, Yeo G, Schafer AJ, O'Rahilly S, Whitehead JP: Genetic variants of insulin receptor substrate-1 (IRS-1) in syndromes of severe insulin resistance. Functional analysis of Ala513Pro and Gly1158Glu IRS-1. Diabet.Med 19:804-809, 2002

26. Del Prato S, Tiengo A: Pancreatic Diabetes. Diabetes Reveiw 1:260, 1993

27. Conte D, Manachino D, Colli A, Guala A, Aimo G, Andreoletti M, Corsetti M, Fraquelli M: Prevalence of genetic hemochromatosis in a cohort of Italian patients with diabetes mellitus. Ann.Intern.Med 128:370-373, 1998

28. Phelps G, Chapman I, Hall P, Braund W, Mackinnon M: Prevalence of genetic haemochromatosis among diabetic patients. Lancet 2:233-234, 1989

29. Handwerger S, Roth J, Gorden P, Di Sant' AP, Carpenter DF, Peter G: Glucose intolerance in cystic fibrosis. N.Engl.J Med 281:451-461, 1969

30. Moran A, Pyzdrowski KL, Weinreb J, Kahn BB, Smith SA, Adams KS, Seaquist ER: Insulin sensitivity in cystic fibrosis. Diabetes 43:1020-1026, 1994

31. Fisher WE: Diabetes: risk factor for the development of pancreatic cancer or manifestation of the disease? World J Surg. 25:503-508, 2001

32. Permert J, Ihse I, Jorfeldt L, von Schenck H, Arnquist HJ, Larsson J: Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br.J Surg. 80:1047-1050, 1993

33. Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, D'Angeli F, Del Favero G, Plebani M: Diabetes mellitus in pancreatic cancer follow-up. Anticancer Res 14:2827-2830, 1994

34. Liu J, Knezetic JA, Strommer L, Permert J, Larsson J, Adrian TE: The intracellular mechanism of insulin resistance in pancreatic cancer patients. J Clin Endocrinol.Metab 85:1232-1238, 2000

35. Valerio A, Basso D, Brigato L, Ceolotto G, Baldo G, Tiengo A, Plebani M: Glucose metabolic alterations in isolated and perfused rat hepatocytes induced by pancreatic cancer conditioned medium: a low molecular weight factor possibly involved. Biochem.Biophys.Res Commun. 257:622-628, 1999

36. Wass JA, Cudworth AG, Bottazzo GF, Woodrow JC, Besser GM: An assessment of glucose intolerance in acromegaly and its response to medical treatment. Clin Endocrinol.(Oxf) 12:53-59, 1980

37. Granda OP, Simonson DC: Growth hormone, acromegaly, and diabetes. Diabetes Reviews 1:286, 1993

38. Boyle PJ: Cushing's disease, glucocorticoid excess, glucocorticoid deficiency and diabetes. Diabetes Reveiw 1:301, 1993

39. Cryer PE: Catecholamines, pheochromocytoma and diabetes. Diabetes Reviews 1:309, 1993

40. Boden G, Ruiz J, Chen X: Glucagonoma syndrome, glucagons and glucose tolerance. Diabetes Reviews 1:352, 1993

41. Garg A, Grundy SM: Nicotinic acid as therapy for dyslipidemia in non-insulin-dependent diabetes mellitus. JAMA 264:723-726, 1990

42. Grundy SM, Vega GL, McGovern ME, Tulloch BR, Kendall DM, Fitz-Patrick D, Ganda OP, Rosenson RS, Buse JB, Robertson DD, Sheehan JP: Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. Arch.Intern.Med 162:1568-1576, 2002

43. Chan JC, Cockram CS, Critchley JA: Drug-induced disorders of glucose metabolism. Mechanisms and management. Drug Saf 15:135-157, 1996

44. Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D, Andres R: Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32:106-111, 1983

45. Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F: Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial. Ann.Intern.Med 126:955-959, 1997

46. Jacob S, Rett K, Wicklmayr M, Agrawal B, Augustin HJ, Dietze GJ: Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens. 14:489-494, 1996

47. Wicklmayr M, Rett K, Dietze G, Mehnert H: Effects of beta-blocking agents on insulin secretion and glucose disposal. Horm.Metab Res Suppl 22:29-33, 1990

48. Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen RA, Schambelan M, Grunfeld C: Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS 15:F11-F18, 2001

49. Murata H, Hruz PW, Mueckler M: Indinavir inhibits the glucose transporter isoform Glut4 at physiologic concentrations. AIDS 16:859-863, 2002

50. Woerle HJ, Mariuz PR, Meyer C, Reichman RC, Popa EM, Dostou JM, Welle SL, Gerich JE: Mechanisms for the deterioration in glucose tolerance associated with HIV protease inhibitor regimens. Diabetes 52:918-925, 2003

51. Osei K, Falko JM, Nelson KP, Stephens R: Diabetogenic effect of pentamidine. In vitro and in vivo studies in a patient with malignant insulinoma. Am J Med 77:41-46, 1984

52. Uzzan B, Bentata M, Campos J, Mosnier A, Krivitzky A, Perret GY, Modigliani E: Effects of aerosolized pentamidine on glucose homeostasis and insulin secretion in HIV-positive patients: a controlled study. AIDS 9:901-907, 1995

53. Forrest JM, Menser MA, Burgess JA: High frequency of diabetes mellitus in young adults with congenital rubella. Lancet 2:332-334, 1971

54. Hyoty H, Hiltunen M, Knip M, Laakkonen M, Vahasalo P, Karjalainen J, Koskela P, Roivainen M, Leinikki P, Hovi T, .: A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 44:652-657, 1995

55. Pak CY, Eun HM, McArthur RG, Yoon JW: Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2:1-4, 1988

56. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P: Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N.Engl.J Med 322:1555-1560, 1990

57. Marchand-Brustel Y, Gorden P, Flier JS, Kahn CR, Freychet P: Anti-insulin receptor antibodies inhibit insulin binding and stimulate glucose metabolism in skeletal muscle. Diabetologia 14:311-317, 1978